Skip to content

trial to evaluate the efficacy of inducing vomiting ie mridu vamana and internal administration of bark of Butea monosperma in the form of decoction in reduced mebstrual bleeding with or without regular cycles in diagnosed cases of polycystic ovary

an open label single arm clinical study to evaluate the combined effect of mrdu vamana and palasa twak kashaya in artavakshaya in diagnosed case of polycystic ovarian disease.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/05/013951
Enrollment
20
Registered
2018-05-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- diagnosed case of polycystic ovary with artavakshaya Health Condition 2: N915- Oligomenorrhea, unspecified

Interventions

Intervention1: nil: nil Intervention2: Internal medication mrdu vamama and palasa twak kashaya internally: DRUG SCHEDULE: Ashta chÅ«rnam (12gms) for 2 days before food, then SukumÄ?ra ghritam 25 gm bd

Sponsors

AKHILA AK
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age group 18 to 35 Both married and unmarried Patients with polycystic ovary in USG. Either flow duration

Exclusion criteria

Exclusion criteria: Menstrual cycle 64 days Known case of TFT disturbance Lactating mother Patient taking OCP/IUCD Under anti-psychotic, anti-epileptic drugs Known case of tumors of adrenal or pituitary gland Patient having systemic pathology like TB, DM, HTN etc.

Design outcomes

Primary

MeasureTime frame
Change in 1)Duration of menstrual phase 2)Interval between 2 cycles 3)Amount of bleeding Timepoint: 7th day of 2nd menstrual cycle

Secondary

MeasureTime frame
Understanding of artavakshaya in modern termsTimepoint: 18 months

Countries

India

Contacts

Public ContactAkhila A K

AMRITA SCHOOL OF AYURVEDA

drhemavathi.sk@gmail.com9495627215

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026